Invega Sustenna 150 mg Injection 1.5 ml
₹8446*
MRP ₹10300
18% off
₹8755*
MRP ₹10300
15% CB
₹1545 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Invega Sustenna 150 mg Injection 1.5 ml belongs to a group of medicines called 'antipsychotics' used for the treatment of schizophrenia and schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants. Schizophrenia is a mental condition in which the person may feel, hear or see things that are not there, believe things that are not true, or feel unusually suspicious or confused.
Invega Sustenna 150 mg Injection 1.5 ml contains 'Paliperidone' that works by blocking the effects of chemical messengers in the brain (i.e., dopamine and serotonin), thereby helping improve mood, behaviour and thoughts. Invega Sustenna 150 mg Injection 1.5 ml elevates the symptoms of the disease and prevents them from recurring.
Invega Sustenna 150 mg Injection 1.5 ml is for intramuscular injection only. It should be given by experienced healthcare professionals. In some cases, you may experience common side effects such as injection site reactions, sleepiness or drowsiness, feeling restlessness or needing to be constantly moving, dizziness, abnormal muscle movements including tremor (shaking), uncontrolled involuntary movements, shuffling and abnormal movements of your eyes. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Invega Sustenna 150 mg Injection 1.5 ml is restricted to use in people who are sensitive to paliperidone, risperidone, or any excipients in the formulation. Keep your doctor informed about your health condition and medicines to rule out any side effects. Before using Invega Sustenna 150 mg Injection 1.5 ml, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Invega Sustenna 150 mg Injection 1.5 ml is recommended not to use in children. Avoid consuming alcohol with Invega Sustenna 150 mg Injection 1.5 ml as it could lead to increased drowsiness and dizziness. Invega Sustenna 150 mg Injection 1.5 ml may impair your ability to make judgements, think clearly, or respond fast. Do not drive, operate heavy machinery, or engage in any other risky activity.
Invega Sustenna 150 mg Injection 1.5 ml belongs to a group of medicines called antipsychotics used to treat schizophrenia in adults. Invega Sustenna 150 mg Injection 1.5 ml improves mood and behaviour in people with an imbalance of chemicals known as neurotransmitters in their brains. Thus, Invega Sustenna 150 mg Injection 1.5 ml relieves psychotic symptoms like delusions, hallucinations, confusion, disturbing thoughts and lack of self-awareness.
Let your doctor know before prescribing Invega Sustenna 150 mg Injection 1.5 ml if you are sensitive to paliperidone, risperidone, or any excipients in the formulation. Keep your doctor informed about your health condition and medicines to rule out any side effects. Before using the Invega Sustenna 150 mg Injection 1.5 ml, inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. Invega Sustenna 150 mg Injection 1.5 ml is recommended not to use in children. Avoid consuming alcohol with Invega Sustenna 150 mg Injection 1.5 ml as it could lead to increased drowsiness and dizziness. Invega Sustenna 150 mg Injection 1.5 ml has the potential to impair your capacity to make judgements, think clearly, or respond swiftly. Avoid being dehydrated or overheated.
Drug-Drug Interactions: Invega Sustenna 150 mg Injection 1.5 ml may have interaction with antipsychotic medicines (e.g. haloperidol), medicines used to treat anxiety and sleeping problems (e.g. lorazepam), anti-depression medications (e.g. duloxetine), anti-allergic medications (e.g. diphenhydramine) and medicines used to treat schizophrenia and bipolar disorder (aripiprazole).
Drug-Food Interactions: Invega Sustenna 150 mg Injection 1.5 ml may interact with alcohol. Avoid the consumption of alcoholic beverages.
Drug-Disease Interactions: Invega Sustenna 150 mg Injection 1.5 ml may have interactions with disease conditions including dementia (memory loss), irregular heartbeat (with QT interval prolongation), Neuroleptic Malignant Syndrome, aspiration, seizure, hematologic abnormalities, hyperglycemia/diabetes, hypotension, lipid alterations, priapism, weight gain, depression, hyperprolactinemia, tardive dyskinesia, antiemetic effect and gastrointestinal obstruction.
Schizophrenia: It is a condition where a person experiences unusually suspicious or confused feelings, believes things that are not true, or perceives, hears, or feels things that are not there. Hallucinations, delusions, movement disorders, disordered thinking, loss of interest, lack of emotions, and more are among the symptoms.
Country of origin
Manufacturer/Marketer address
Alcohol
Caution
Avoid consumption of alcohol while taking Invega Sustenna 150 mg Injection 1.5 ml as it may cause increased drowsiness and lower your blood pressure.
Pregnancy
Caution
Invega Sustenna 150 mg Injection 1.5 ml is not recommended for use in pregnancy unless clearly necessary. So, inform your doctor if you are pregnant or suspect pregnancy. Your doctor will weigh the benefits and potential risks before prescribing Invega Sustenna 150 mg Injection 1.5 ml.
Breast Feeding
Caution
Caution should be exercised. Invega Sustenna 150 mg Injection 1.5 ml is not recommended for use in breastfeeding unless clearly necessary. So, inform your doctor if you are a nursing mother. Your doctor will weigh the benefits and potential risks before prescribing Invega Sustenna 150 mg Injection 1.5 ml.
Driving
Unsafe
Invega Sustenna 150 mg Injection 1.5 ml may affect your ability to make decisions, think clearly, or react quickly. Do not drive, operate heavy machinery, or do other dangerous activities.
Liver
Caution
Inform your doctor if you have a liver impairment. Your doctor may adjust the dose or prescribe a suitable alternative based on your condition.
Kidney
Caution
Inform your doctor if you have kidney impairment. Your doctor may adjust the dose or prescribe a suitable alternative based on your condition.
Children
Unsafe
The safety and efficacy of Invega Sustenna 150 mg Injection 1.5 ml are not established in children under the age of 18 years.
Product Substitutes
We provide you with authentic, trustworthy and relevant information